GDF15 Modulator Inhibits Cardiac Dysfunction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating cardiac conditions such as congestive heart failure are inadequate, as they do not effectively address the underlying issues related to GDF15 activity, which is associated with heart injury and failure.
Innovation Solution
A composition that selectively reduces or inhibits GDF15 activity by binding to its endogenous binding partners or neutralizing its activity, using antibodies or peptides, to treat cardiac disorders and improve cardiac function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional methods are used to treat cardiac conditions, then treatment is provided, but the underlying issues related to GDF15 activity are not effectively addressed
Solution Approach 1:
The patent introduces GDF15 modulators as intermediary substances that specifically target and modulate GDF15 activity. These modulators act as mediators between the therapeutic agent and the pathological process, selectively binding to GDF15 or its receptors to regulate its activity in cardiac conditions, thereby addressing the underlying mechanism that conventional treatments miss.
2Reliability
If GDF15 activity is reduced or inhibited, then cardiac function is improved, but the mechanism requires selective modulation rather than general treatment
Solution Approach 1:
The patent applies local quality by designing GDF15 modulators with specific molecular structures that confer selective affinity for GDF15 or its receptors. This selectivity is achieved through localized structural features of the modulator molecules that match specific binding sites on GDF15, enabling targeted modulation without affecting other cardiac proteins or pathways.
Solution Approach 2:
The patent utilizes parameter changes by modifying physical and chemical properties of GDF15 modulators to optimize their binding affinity, specificity, and pharmacokinetic characteristics. By adjusting parameters such as molecular weight, charge distribution, and hydrophobicity, the modulators achieve selective GDF15 inhibition while maintaining stability and efficacy in the cardiac environment.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The approach effectively treats cardiac conditions by reducing GDF15 activity, improving cardiac function, and alleviating symptoms such as reduced peak oxygen consumption and elevated biomarkers, thereby enhancing the management of congestive heart failure.
Implementation Method 1
A composition that selectively reduces or inhibits GDF15 activity by binding to its endogenous binding partners
Data Source
AI summary
The invention provides methods and compositions of treating a subject having a cardiac-related disorder such as congestive or chronic heart failure (CHF), cardiac hypertrophy, cardiac hypotrophy, and other cardiac myopathies/dystrophies. The methods comprise administering an effective amount of a composition that modulates, for example, reduces or inhibits, GDF15 activity in the subject.